Furthermore, the data confirmed that the effect of hyperuricemia is due to a shortage of fibroblast-derived lumican, which in turn promotes fibroblast activation and fibrotic function via the TGFβ/SMAD signaling pathway. The gene discussed is TGFB1; the disease is hyperuricemia.